This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.
Automatically generated on October 27, 2022.
Return to the list of Patented Medicine Litigation page.
Donepezil
ARICEPT, ARICEPT RDT – Pfizer Canada Inc. (NOC Search)
Patents:
- 1338808: EISAI, APOTEX, GENPHARM, EISAI, MYLAN, RATIOPHARM, EISAI, EISAI, MYLAN, RANBAXY, EISAI, EISAI, MINT, ACTAVIS, EISAI, PHARMASCIENCE, EISAI
- 2252806: EISAI, MINT, EISAI, ACCORD HEALTHCARE, RATIOPHARM, EISAI, RANBAXY, EISAI, EISAI, APOTEX, GENPHARM, EISAI, MYLAN, ACTAVIS, EISAI, PHARMASCIENCE, EISAI, EISAI, AURO, EISAI, EISAI, SANDOZ
ACTAVIS, EISAI
AURO, EISAI
- PM(NOC) – T-1033-12
EISAI
- PM(NOC) – T-414-12
EISAI, ACCORD HEALTHCARE
- PM(NOC) – T-1032-12
EISAI, APOTEX
EISAI, MINT
- PM(NOC) – T-12-12
EISAI, MYLAN
- Appeal – A-226-11 (2012 FCA 103)
EISAI, SANDOZ
- PM(NOC) – T-103-10
GENPHARM, EISAI, MYLAN
- PM(NOC) – T-1118-09 (2010 FC 684, 2011 FC 547)
PHARMASCIENCE, EISAI
RANBAXY, EISAI
- PM(NOC) – T-2184-10
RATIOPHARM, EISAI
- PM(NOC) – T-713-10
Return to the Patented Medicine Litigation page.